A new nano-based drug delivery technology could outwit tuberculosis (TB)—one of humanity's most ancient diseases.

A new compound called CMX410 may change the fight against tuberculosis. It targets a weak point in the bacteria’s defenses, ...

A team of researchers at the University of Witwatersrand are developing a system of medicine delivery at the nano scale to ...

NEW YORK – Danaher subsidiary Cepheid announced on Tuesday that its Xpert MTB/XDR test for tuberculosis drug resistance has been awarded prequalification status by the World Health Organization.

GlaxoSmithKline (GSK) has recently completed a Phase 2A clinical study titled A Parallel Group, Phase 2A, Randomised, Open Label Treatment Study to Assess the Early Bactericidal Activity, Safety and ...

•Lari level 4 hospital TB and respiratory coordinator Dr Patricia Mwangi said the most affected are male patients. •Mwangi revealed that out of more than 5,000 cases of people diagnosed with TB in the ...

xRespiratory Epidemiology and Clinical Research Unit, Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montréal, QC, Canada yDepartment of Global ...

An elderly woman's x-ray revealed the bizarre treatment she received decades earlier to treat the world's deadliest disease, ...

A Hospital consultant was apologetic to the relatives of a woman who died from a toxic side-effect of a drug prescribed to treat her latent tuberculosis. At the inquest into the death of Dymphna Dykes ...

Copyright: © 2025 The Author(s). Published by Elsevier Ltd. Between Nov 19 and Dec 3, 2020, 114 clinics were screened, of which 29 were randomly assigned and ...

Tuberculosis remains one of the world's deadliest infectious diseases, disproportionately affecting populations grappling with poverty and undernutrition. For decades, tuberculosis control strategies ...